Grill, Christine ; Université de Liège - ULiège > Département de pharmacie > Chimie médicale ; Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France ; University Paris-Sud, University Paris-Saclay, CNRS, UMR 3347, Orsay, France ; Equipe Labellisée Ligue Contre le Cancer, Orsay, France
Benzekri, L.; Mohammed V University in Rabat, Department of Dermatology, Ibn Sina University Hospital, Rabat, Morocco
Rubod, A.; Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France ; University Paris-Sud, University Paris-Saclay, CNRS, UMR 3347, Orsay, France ; Equipe Labellisée Ligue Contre le Cancer, Orsay, France
Aktary, Z.; Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France ; University Paris-Sud, University Paris-Saclay, CNRS, UMR 3347, Orsay, France ; Equipe Labellisée Ligue Contre le Cancer, Orsay, France
Ezzedine, K. ; Department of Dermatology and Pediatric Dermatology, National Reference Centre for Rare Skin Disorders, Hôpital Saint-André, Bordeaux, France ; INSERM U1035, University of Bordeaux, Bordeaux, France
Taïeb, A.; Department of Dermatology and Pediatric Dermatology, National Reference Centre for Rare Skin Disorders, Hôpital Saint-André, Bordeaux, France ; INSERM U1035, University of Bordeaux, Bordeaux, France
Gauthier, Y.; Department of Dermatology and Pediatric Dermatology, National Reference Centre for Rare Skin Disorders, Hôpital Saint-André, Bordeaux, France ; INSERM U1035, University of Bordeaux, Bordeaux, France
Larue, L. ; Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France ; University Paris-Sud, University Paris-Saclay, CNRS, UMR 3347, Orsay, France ; Equipe Labellisée Ligue Contre le Cancer, Orsay, France
Delmas, V.; Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France ; University Paris-Sud, University Paris-Saclay, CNRS, UMR 3347, Orsay, France ; Equipe Labellisée Ligue Contre le Cancer, Orsay, France
Language :
English
Title :
Epidermal melanocytes in segmental vitiligo show altered expression of E-cadherin, but not P-cadherin
(Picardo M, Taïeb A, eds). Vitiligo. Heildelberg: Springer-Verlag, 2010.
Ezzedine K, Lim HW, Suzuki T et al. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res 2012; 25:E1–13.
van Geel N, Speeckaert R. Segmental vitiligo. Dermatol Clin 2017; 35:145–50.
van Geel N, Speeckaert R, Mollet I et al. In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial. Pigment Cell Melanoma Res 2012; 25:57–65.
Anbar TS, El-Badry MM, McGrath JA et al. Most individuals with either segmental or non-segmental vitiligo display evidence of bilateral cochlear dysfunction. Br J Dermatol 2015; 172:406–11.
Wagner RY, Luciani F, Cario-Andre M et al. Altered E-cadherin levels and distribution in melanocytes precede clinical manifestations of vitiligo. J Invest Dermatol 2015; 135:1810–19.
Niessen CM, Leckband D, Yap AS. Tissue organization by cadherin adhesion molecules: dynamic molecular and cellular mechanisms of morphogenetic regulation. Physiol Rev 2011; 91:691–731.
Gauthier Y, Cario-Andre M, Lepreux S et al. Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo. Br J Dermatol 2003; 148:95–101.
